Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Allergan, Inc.    AGN

No quotes available
-- USD   0.00%
02/08 PFIZER : Allergan deal prompts Pfizer to name new executives to run ..
02/08 PFIZER : Executive leadership team named for the combined Allergan P..
02/08 Pfizer unveils management line up for combined company
SummaryQuotesNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsSector news 

Allergan, Inc. : Allergan Gets Subpoena From Government Over Lap-Band System

05/07/2012 | 06:11pm US/Eastern
   By Anjali Athavaley 
   Of  
 

Allergan Inc. (AGN) received a subpoena this month from the Department of Health and Human Services requesting documents related to the company's Lap-Band System for obesity, according to a filing.

Lap-Band is approved to help obese patients lose weight. It is inserted surgically through a small incision and placed at the top of the stomach. The inflatable band can be tightened or loosened to reduce or enlarge stomach capacity.

An Allergan spokeswoman declined to comment further.

Earlier this month, Allergan said its first-quarter earnings rose 45% on double-digit sales growth in its specialty-pharmaceuticals business. But sales in Allergan's obesity intervention category slipped 15.5% as high unemployment, lofty co-payments and rigid requirements from insurers pressured sales.

Last December, the U.S. Food and Drug Administration warned nine groups, mostly surgical centers in California, that if they continue misleading advertising for Lap-Band, they could face monetary penalties and have inventory seized. The FDA made no allegations against Allergan at the time.

Allergan shares were up fractionally to $93.79 in after-hours trading Monday. The stock is up nearly 7% so far this year.

-By Anjali Athavaley, Dow Jones Newswires; 212-416-4912; anjali.athavaley@dowjones.com

React to this article
Latest news on ALLERGAN, INC.
02/08 PFIZER : Allergan deal prompts Pfizer to name new executives to run units
02/08 PFIZER : Executive leadership team named for the combined Allergan Pfizer busine..
02/08 Pfizer unveils management line up for combined company
02/05 ALLERGAN : ALASTIN Skincare, Inc. Announces Appointment of Lynn Salo to Company'..
02/02 Pfizer 2016 forecast disappoints
02/02 Pfizer forecasts 2016 revenue, earnings below estimates
02/02 ALLERGAN : signs global agreement with AstraZeneca
02/01 ALLERGAN : Enters into Co-Development Agreement with AstraZeneca
01/31 ALLERGAN : US regulator asked to nix Teva-Allergan generics merger
01/29 ALLERGAN : Announces Collaboration with AstraZeneca to Develop and Commercialize..
Advertisement
Income Statement Evolution
More Financials